Jojo Health, Inc. — SEC Form D Filing
Jojo Health, Inc. filed an SEC Form D on September 9, 2026, reporting $50K raised in Health Technology.
Form D filing details
- Filing
- SEC Form D
- Filing date
- September 9, 2026
- Amount reported
- $50K
- Round stage
- Seed
- Industry
- Health Technology
- Website
- https://jojo.health/
What the company does
Securities: Simple Agreement for Future Equity (SAFE). Revenue: No Revenues. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Seniors face challenges with early detection of cognitive changes, which can impact their ability to maintain independence.
Solution
Jojo is a voice AI device that uses cognitive testing and vocal biomarker analysis within casual conversation to track cognitive function and surface early signs of cognitive drift.
Why now
Advances in AI, particularly voice AI and natural language processing, combined with growing awareness of proactive brain health, make it possible to offer continuous, non-invasive cognitive monitoring at home.
Verdict
This cleared because investors saw a low-cost, low-risk way to explore voice AI's potential in a clear, underserved market segment, not because the technology itself was fully de-risked or unique. They were implicitly betting on the continued growth of aging-in-place trends and the eventual commoditization of voice biomarker analysis for consumer health. What limited upside or durability was the lack of immediate clinical validation and the potential for larger tech platforms to absorb similar capabilities.
Source: SEC EDGAR Form D filing